Erlotinib and the risk of oral cancer the erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial

William N. William, Vassiliki Papadimitrakopoulou, J. Jack Lee, Li Mao, Ezra E.W. Cohen, Heather Y. Lin, Ann M. Gillenwater, Jack W. Martin, Mark W. Lingen, Jay O. Boyle, Dong M. Shin, Nadarajah Vigneswaran, Nancy Shinn, John V. Heymach, Ignacio I. Wistuba, Ximing Tang, Edward S. Kim, Pierre Saintigny, Elizabeth A. Blair, Timothy MeillerJ. Silvio Gutkind, Jeffrey Myers, Adel El-Naggar, Scott M. Lippman

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'Erlotinib and the risk of oral cancer the erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences